Cargando…
S100 as Serum Tumor Marker in Advanced Uveal Melanoma
SIMPLE SUMMARY: Our study looked at the usefulness of a protein called S100 in monitoring the progression of uveal melanoma, a type of black skin cancer first growing in the eye. We found that only a small number of patients had high levels of S100 in their blood when the cancer had first spread to...
Autores principales: | Salzmann, Martin, Enk, Alexander H., Hassel, Jessica C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046712/ https://www.ncbi.nlm.nih.gov/pubmed/36979464 http://dx.doi.org/10.3390/biom13030529 |
Ejemplares similares
-
Anti‐PD‐1 antibodies in metastatic uveal melanoma: a treatment option?
por: Bender, Carolin, et al.
Publicado: (2017) -
Immunotherapies for the Treatment of Uveal Melanoma—History and Future
por: Schank, Timo E., et al.
Publicado: (2019) -
Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy
por: Salzmann, Martin, et al.
Publicado: (2022) -
TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022) -
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients
por: Salzmann, Martin, et al.
Publicado: (2020)